Serge Belanger
Stock Analyst at Needham
(4.36)
# 423
Out of 4,948 analysts
372
Total ratings
55.01%
Success rate
15.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMER Omeros | Reiterates: Hold | n/a | $4.41 | - | 8 | Aug 15, 2025 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Buy | $36 | $29.86 | +20.56% | 6 | Aug 12, 2025 | |
| LQDA Liquidia | Maintains: Buy | $32 → $36 | $25.95 | +38.73% | 33 | Aug 12, 2025 | |
| HRTX Heron Therapeutics | Maintains: Buy | $4 → $3 | $1.33 | +125.56% | 23 | Aug 8, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $24 → $22 | $7.52 | +192.75% | 22 | Aug 8, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $20 → $22 | $16.89 | +30.25% | 22 | Aug 7, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $36 → $34 | $18.54 | +83.39% | 18 | Aug 6, 2025 | |
| EOLS Evolus | Downgrades: Hold | $22 | $6.73 | +226.89% | 16 | Aug 6, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $15 | $12.62 | +18.86% | 4 | Aug 5, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $17 | $8.37 | +103.11% | 16 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $3 | $0.42 | +609.22% | 16 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $12.93 | +54.68% | 18 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $25.07 | +59.55% | 9 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.96 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $38.67 | +86.19% | 23 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $66 | $54.42 | +21.28% | 13 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $38.23 | +43.87% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $24.78 | +21.07% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.05 | +95.12% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $37.71 | +21.98% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $12.88 | +117.39% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.25 | - | 1 | Mar 31, 2022 |
Omeros
Aug 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.41
Upside: -
Amphastar Pharmaceuticals
Aug 12, 2025
Upgrades: Buy
Price Target: $36
Current: $29.86
Upside: +20.56%
Liquidia
Aug 12, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $25.95
Upside: +38.73%
Heron Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.33
Upside: +125.56%
Trevi Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $7.52
Upside: +192.75%
Arcutis Biotherapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $16.89
Upside: +30.25%
Viridian Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $18.54
Upside: +83.39%
Evolus
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $6.73
Upside: +226.89%
Ocular Therapeutix
Aug 5, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $12.62
Upside: +18.86%
BioCryst Pharmaceuticals
Aug 4, 2025
Maintains: Buy
Price Target: $17
Current: $8.37
Upside: +103.11%
Jul 17, 2025
Downgrades: Hold
Price Target: $3
Current: $0.42
Upside: +609.22%
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $12.93
Upside: +54.68%
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $25.07
Upside: +59.55%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.96
Upside: -
May 14, 2025
Reiterates: Buy
Price Target: $72
Current: $38.67
Upside: +86.19%
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $54.42
Upside: +21.28%
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $38.23
Upside: +43.87%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $24.78
Upside: +21.07%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $2.05
Upside: +95.12%
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $37.71
Upside: +21.98%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $12.88
Upside: +117.39%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $3.25
Upside: -